Pharmacoeconomic Analysis of the Inclusion of Rivaroxaban in the Current Algorithms Prevention of the Stroke in Patients With Atrial Fibrillation

被引：0
|
作者：
Kulikov, A. Yu. [1 ]
Protsenko, M. V. [1 ]
Serdechnaya, E. V. [2 ]
机构：
[1] Sechenov First Moscow State Med Univ, Moscow, Russia
[2] Northern State Med Univ, Arkhangelsk, Russia
来源：
KARDIOLOGIYA | 2016年 / 56卷 / 11期
关键词：
ANTICOAGULATION;
D O I：
10.18565/cardio.2016.11.71-77
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：71 / 77
页数：7
相关论文
共 50 条
  • [1] RIVAROXABAN IN PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION
    Simonyi Gabor
    Medvegy Mihaly
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2012, 65 (11-12): : 365 - 368
  • [2] A Pharmacoeconomic Perspective on Stroke Prevention in Atrial Fibrillation
    Fendrick, A. Mark
    AMERICAN JOURNAL OF MANAGED CARE, 2010, 16 (10): : S284 - S290
  • [3] PHARMACOECONOMIC ANALYSIS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION: COMPARISON WITH RIVAROXABAN OR APIXABAN
    Gay-Molina, J. G.
    Herran, S.
    Sorensen, S.
    Gonschior, A. K.
    VALUE IN HEALTH, 2014, 17 (03) : A115 - A115
  • [4] Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence
    Martinez-Rubio, Antoni
    Andrei Dan, George
    Carlos Kaski, Juan
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (08) : 933 - 947
  • [5] Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer
    Laube, Eva S.
    Yu, Anthony
    Gupta, Dipti
    Miao, Yimei
    Samedy, Patrick
    Wills, Jonathan
    Harnicar, Stephen
    Soff, Gerald A.
    Mantha, Simon
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (02): : 213 - 217
  • [6] Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
    Mensch, Alexander
    Stock, Stephanie
    Stollenwerk, Bjoern
    Mueller, Dirk
    PHARMACOECONOMICS, 2015, 33 (03) : 271 - 283
  • [7] Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
    Alexander Mensch
    Stephanie Stock
    Björn Stollenwerk
    Dirk Müller
    PharmacoEconomics, 2015, 33 : 271 - 283
  • [8] Use of rivaroxaban for the prevention of stroke in patients with nonvalvular atrial fibrillation in Spain
    Marti, Edelmira
    Segado, Alejandra
    Pastor-Galan, Irene
    Amat, Paula
    Jose Remigia, Maria
    Solano, Carlos
    Navarro, Blanca
    FUTURE CARDIOLOGY, 2018, 14 (03) : 3 - 8
  • [9] Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
    Kourlaba, Georgia
    Maniadakis, Nikos
    Andrikopoulos, George
    Vardas, Panos
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2014, 12
  • [10] Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
    Georgia Kourlaba
    Nikos Maniadakis
    George Andrikopoulos
    Panos Vardas
    Cost Effectiveness and Resource Allocation, 12
12345